Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation

Ertas M., Sahin Z., BERK B., YURTTAŞ L., Biltekin S. N., DEMİRAYAK Ş.

ARCHIV DER PHARMAZIE, cilt.351, sa.3-4, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 351 Sayı: 3-4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1002/ardp.201700272
  • Dergi Adı: ARCHIV DER PHARMAZIE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Index Chemicus (IC)
  • Anahtar Kelimeler: anticancer activity, aromatase, breast cancer, MCF-7, non-steroidal inhibitor, ADVANCED BREAST-CANCER, FIRST-LINE THERAPY, HERG K+ CHANNELS, ESTROGEN BIOSYNTHESIS, POSTMENOPAUSAL WOMEN, RESVERATROL, ANALOGS, MECHANISM, PROLIFERATION, OPTIMIZATION
  • Anadolu Üniversitesi Adresli: Evet

Özet

Drugs used in breast cancer treatments target the suppression of estrogen biosynthesis. During this suppression, the main goal is to inhibit the aromatase enzyme that is responsible for the cyclization and structuring of estrogens either with steroid or non-steroidal-type inhibitors. Non-steroidal derivatives generally have a planar aromatic structure attached to the triazole ring system in their structures, which inhibits hydroxylation reactions during aromatization by coordinating the heme group. Bioisosteric replacement of the triazole ring system and development of aromatic/cyclic structures of the side chain can increase the selectivity for aromatase enzyme inhibition. In this study, pyridine-substituted thiazolylphenol derivatives, which are non-steroidal triazole bioisosteres, were synthesized using the Hantzsch method, and physical analysis and structural determination studies were performed. The IC50 values of the compounds were determined by a fluorescence-based aromatase inhibition assay. Then, their antiproliferative activities on the MCF7 and HEK 293 cell lines were evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Furthermore, the crystal structure of human placental aromatase was subjected to a series of docking experiments to identify the possible interactions between the most active structure and the active site. Lastly, an in silico technique was performed to analyze and predict the drug-likeness, molecular and ADME properties of the synthesized molecules.